MEP of the week

Lobby organisation

BioMarin UK Limited

Company · Health & pharma · HQ: United Kingdom · Transparency Register entry

As of 7 November 2026, BioMarin UK Limited appears in 10 declared MEP meetings (10 different MEPs), most often with European People's Party.

10
declared meetings
with current MEPs
10
MEPs met
€200k/yr
declared lobbying spend
self-reported to the register
0.5
lobbyists
full time equivalent

In their own words

“BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare diseases and medical conditions. Our therapy portfolio consists of several commercialised products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.BioMarin.com […]”

Stated goals from the organisation's own Transparency Register filing - the text on file breaks off mid-sentence where marked […].

Who they meet, and when

Which groups they meet

Share of this organisation's 10 declared meetings, by the meeting MEP's political group.

European People's Party440%
Renew Europe330%
Socialists & Democrats220%
European Conservatives & Reformists110%

Meetings by year

Declared meetings per calendar year, 2022–2026. Bar length is relative to its busiest year (5 in 2024). Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.

2022
1
2023
2
2024
5
2025
1
2026
1

Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.

The MEPs they meet most

Tiemo Wölken
1 meeting · S&D
Dolors Montserrat
1 meeting · EPP
Susana Solís Pérez
1 meeting · EPP
Billy Kelleher
1 meeting · Renew

The 10 most recent declared meetings

DateMEPSubject
16 Apr 2026Stine BosseBiotech Act
4 Feb 2025Michael McNamaraTechnologies developed for rare diseases
17 Oct 2024András Tivadar KuljaEU biotechnology
15 Oct 2024Francesco TorselliIncontro conoscitivo per discutere delle nuove proposte regolatorie in tema di salute e malattie rare
8 Oct 2024Dolors MontserratNew EU Pharmaceutical Legislation
25 Sep 2024Billy KelleherEU Health Policy
30 Jan 2024Nicolás González CasaresPharma legislation
7 Jun 2023Tiemo WölkenRevision of Pharmaceutical Legislation (staff level)
30 Jan 2023Sirpa PietikäinenEU’s action in the field of rare diseases
8 Nov 2022Susana Solís PérezEHDS

Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.